Category B
Bioregulator Peptides
Short, organ-targeted peptides.
- Compounds
- 14
- Human data
- 0
This category holds 14 compounds. By evidence level: 11 preclinical, 3 little public data. The badge describes the published research, not the product. How to read the badges.
-
PreclinicalBR
Bronchogen
Bioregulator tetrapeptide
Synthetic bioregulator tetrapeptide from the Khavinson programme, studied for effects on gene expression in bronchial epithelial cells.
- 20 mg
-
Little dataCH
Chonluten
Bioregulator tripeptide
Synthetic bioregulator tripeptide Glu-Asp-Gly from the Khavinson programme, studied for effects on gene expression and cytokine signalling.
- 20 mg
-
PreclinicalCAR
Cardiogen
Bioregulator tetrapeptide
Synthetic bioregulator tetrapeptide Ala-Glu-Asp-Arg from the Khavinson programme, studied in cardiac-tissue cells and animal ischaemia models.
- 10 mg
- 20 mg
-
PreclinicalCART
Cartalax
Bioregulator tripeptide
Synthetic bioregulator tripeptide Ala-Glu-Asp from the Khavinson programme, studied in cultured fibroblast, kidney and stem cells for ageing markers.
- 10 mg
- 20 mg
-
Little dataCRY
Crystagen
Bioregulator peptide
Bioregulator tripeptide Glu-Asp-Pro from the Khavinson programme, described as an immune-system regulator and reported as a Thymalin component.
- 10 mg
- 20 mg
-
PreclinicalCOR
Cortagen
Bioregulator tetrapeptide
Synthetic bioregulator tetrapeptide Ala-Glu-Asp-Pro, designed from Cortexin, studied for nerve regeneration, brain ischaemia and gene expression.
- 20 mg
-
PreclinicalLI
Livagen
Bioregulator peptide
Synthetic bioregulator tetrapeptide Lys-Glu-Asp-Ala, described as a liver peptide, studied for chromatin and ribosomal-gene effects in vitro.
- 20 mg
-
PreclinicalOVA
Ovagen
Bioregulator peptide
Synthetic bioregulator tripeptide Glu-Asp-Leu from the Khavinson programme, studied in rat kidney injury models and kidney cell cultures.
- 10 mg
- 20 mg
-
PreclinicalPA
Pancragen
Bioregulator peptide
Synthetic bioregulator tetrapeptide Lys-Glu-Asp-Trp, described as a pancreatic regulator, studied in pancreatic cell cultures and diabetic rat models.
- 20 mg
-
PreclinicalPIN
Pinealon
Bioregulator tripeptide
Synthetic bioregulator tripeptide Glu-Asp-Arg studied as a neuroprotective peptide, with research on reactive oxygen species and DNA interaction.
- 5 mg
- 10 mg
- 20 mg
-
Little dataTG
Testagen
Bioregulator peptide
Bioregulator tetrapeptide Lys-Glu-Asp-Gly, proposed as a male reproductive-tissue regulator; data cover DNA binding in vitro and bird models.
- 10 mg
-
PreclinicalTY
Thymalin
Thymus-derived peptide complex
Calf thymus polypeptide extract reportedly containing Vilon, Thymogen and EDP, studied for T-lymphocyte differentiation and gene expression effects.
- 10 mg
-
Preclinical
Vesugen
Bioregulator tripeptide
Synthetic bioregulator tripeptide Lys-Glu-Asp, described as a vascular-endothelium peptide, studied for gene-expression effects in cell culture.
- 10 mg
- 20 mg
-
PreclinicalVI
Vilon
Bioregulator dipeptide
Synthetic bioregulator dipeptide Lys-Glu, a reported Thymalin component, studied for lymphocyte differentiation and gene expression in cultures.
- 20 mg
No compounds match these filters.
Continue browsing
Other categories
Supply is by inquiry and quotation
Add the compounds and sizes you need to an inquiry list and send it with your contact details. The sales team replies with a quotation.
